<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38456315</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study.</ArticleTitle><Pagination><StartPage>e29486</StartPage><MedlinePgn>e29486</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29486</ELocationID><Abstract><AbstractText>Orthostatic intolerance (OI), including postural orthostatic tachycardia syndrome (PoTS) and orthostatic hypotension (OH), are often reported in long covid, but published studies are small with inconsistent results. We sought to estimate the prevalence of objective OI in patients attending long covid clinics and healthy volunteers and associations with OI symptoms and comorbidities.&#xa0;Participants with a diagnosis of long covid were recruited from eight&#xa0;UK long covid clinics, and healthy volunteers from general population. All undertook standardized National Aeronautics and Space Administration Lean Test (NLT). Participants' history of typical OI symptoms (e.g., dizziness, palpitations) before and during the NLT were recorded.&#xa0;Two hundred seventy-seven long covid patients and 50 frequency-matched healthy volunteers were tested. Healthy volunteers had no history of OI symptoms or symptoms during NLT or PoTS, 10% had asymptomatic OH. One hundred thirty&#xa0;(47%) long covid patients had previous history of OI symptoms and 144 (52%) developed symptoms during the NLT. Forty-one&#xa0;(15%) had an abnormal NLT, 20 (7%) met criteria for PoTS, and 21 (8%) had OH. Of patients with an abnormal NLT, 45% had no prior symptoms of OI. Relaxing the diagnostic thresholds for PoTS from two consecutive abnormal readings to one abnormal reading during the NLT, resulted in 11% of long covid participants (an additional 4%) meeting criteria for PoTS, but not in healthy volunteers.&#xa0;More than half of long covid patients experienced OI symptoms during NLT and more than one in 10&#xa0;patients met the criteria for either PoTS or OH, half of whom did not report previous typical OI symptoms. We therefore recommend all patients attending long covid clinics are offered an NLT and appropriate management commenced.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Cassie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Imperial College Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Darren C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0001-7035-3096</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Master</LastName><ForeName>Harsha</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Covid Assessment and Rehabilitation Service, Hertfordshire Community NHS Trust, Welwyn Garden City, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasundaram</LastName><ForeName>Kumaran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, Respiratory &amp; Infection Theme, Glenfield Hospital, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Covid Assessment and Rehabilitation Service, Hertfordshire Community NHS Trust, Welwyn Garden City, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Development and Innovation Department, NHS Highlands, Inverness, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Conor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Birmingham Community Healthcare, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Rowena</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Development and Innovation Department, NHS Highlands, Inverness, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darbyshire</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Ana Espinosa</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Surgery &amp; Cancer, Imperial College, Faculty of Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Helen E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Wales, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrado</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iftekhar</LastName><ForeName>Nafi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The LOCOMOTION Patient Advisory Group, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery &amp; Cancer, Imperial College, Faculty of Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenhalgh</LastName><ForeName>Trish</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LOCOMOTION Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Institute for Health and Care Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054971" MajorTopicYN="Y">Orthostatic Intolerance</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054972" MajorTopicYN="Y">Postural Orthostatic Tachycardia Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NASA lean test</Keyword><Keyword MajorTopicYN="N">PoTS</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">orthostatic hypotension</Keyword><Keyword MajorTopicYN="N">orthostatic tachycardia</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Mosley</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parkin</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rebane</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lovett</LastName><ForeName>Ashliegh</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Echevarria</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rayner</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winch</LastName><ForeName>Darren</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mir</LastName><ForeName>Ghazala</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tucker-Bell</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>Juliet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Madeline</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ball</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bakerly</LastName><ForeName>Nawar</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Nikki</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Rachael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milne</LastName><ForeName>Ruairidh</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elkin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halpin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falope</LastName><ForeName>Zacchaeus</ForeName><Initials>Z</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38456315</ArticleId><ArticleId IdType="doi">10.1002/jmv.29486</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>NICE. Covid-19 rapid guideline: managing the long-term effects of covid-19. 2020.</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, et al. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621.</Citation></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid-an update for primary care. BMJ. 2022;378:e072117.</Citation></Reference><Reference><Citation>Espinosa-Gonzalez AB, Master H, Gall N, Halpin S, Rogers N, Greenhalgh T. Orthostatic tachycardia after covid-19. BMJ. 2023;380:e073488.</Citation></Reference><Reference><Citation>Campen CMC, Visser FC. Long-haul COVID patients: prevalence of POTS are reduced but cerebral blood flow abnormalities remain abnormal with longer disease duration. Healthcare. 2022;10(10):2105.</Citation></Reference><Reference><Citation>Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020;36(3):357-372.</Citation></Reference><Reference><Citation>Tzur I, Izhakian S, Gorelik O. Orthostatic hypotension: definition, classification and evaluation. Blood Press. 2019;28(3):146-156.</Citation></Reference><Reference><Citation>Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension. J Am Coll Cardiol. 2015;66(7):848-860.</Citation></Reference><Reference><Citation>Sheldon RS, Grubb 2nd BP, Olshansky B, et al. 2015 Heart Rhythm Society Expert Consensus Statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-e63.</Citation></Reference><Reference><Citation>Larsen NW, Stiles LE, Miglis MG. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235:102841.</Citation></Reference><Reference><Citation>Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72.</Citation></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K, et al. The face of postural tachycardia syndrome: insights from a large cross-sectional online community-based survey. J Intern Med. 2019;286(4):438-448.</Citation></Reference><Reference><Citation>Raj V, Opie M, Arnold AC. Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci. 2018;215:46-55.</Citation></Reference><Reference><Citation>Nelson MJ, Bahl JS, Buckley JD, Thomson RL, Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis. Medicine. 2019;98(43):e17600.</Citation></Reference><Reference><Citation>Natelson BH, Lin JMS, Blate M, Khan S, Chen Y, Unger ER. Physiological assessment of orthostatic intolerance in chronic fatigue syndrome. J Transl Med. 2022;20(1):95.</Citation></Reference><Reference><Citation>Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. 2019;322(6):499-500.</Citation></Reference><Reference><Citation>Lee J, Vernon SD, Jeys P, et al. Hemodynamics during the 10-minute NASA lean test: evidence of circulatory decompensation in a subset of ME/CFS patients. J Transl Med. 2020;18(1):314.</Citation></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. 2023;20(5):281-282.</Citation></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19(11):1880-1889.</Citation></Reference><Reference><Citation>Gall NP, James S, Kavi L. Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients. British J&#xa0;Cardiol. 2022;29(1):3.</Citation></Reference><Reference><Citation>Kavi L. Postural tachycardia syndrome and long COVID: an update. Br J Gen Pract. 2022;72(714):8-9.</Citation></Reference><Reference><Citation>Gonzalez-Hermosillo JA, Martinez-Lopez JP, Carrillo-Lampon SA, et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. 2021;11(6).</Citation></Reference><Reference><Citation>Hira R, Baker JR, Siddiqui T, et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can J Cardiol. 2023;39(6):767-775.</Citation></Reference><Reference><Citation>Barbic F, Minonzio M, Cairo B, et al. Work ability assessment and its relationship with cardiovascular autonomic profile in postural orthostatic tachycardia syndrome. Int J Environ Res Public Health. 2020;17(21):7836.</Citation></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vall&#xe9;e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11(1):14042.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in &#x2018;long COVID': rationale, physiology and management strategies. Clin Med. 2021;21(1):e63-e67.</Citation></Reference><Reference><Citation>Hira R, Karalasingham K, Baker JR, Raj SR. Autonomic manifestations of long-COVID syndrome. Curr Neurol Neurosci Rep. 2023;23(12):881-892.</Citation></Reference><Reference><Citation>Rigo S, Barbic F, Khalaf K, et al. The Long-COVID autonomic syndrome in hospitalized patients: a one-year prospective cohort study. Eur J Intern Med. 2024;120:38-45.</Citation></Reference><Reference><Citation>Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28(1):67-81.</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.</Citation></Reference><Reference><Citation>Isaac R, Corrado J, Sivan M. Detecting orthostatic intolerance in long COVID in a clinic setting. Int J Environ Res Public Health. 2023;20(10):5804.</Citation></Reference><Reference><Citation>Sivan M, Greenhalgh T, Darbyshire JL, et al. LOng COvid multidisciplinary consortium optimising treatments and services across the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK. BMJ Open. 2022;12(5):e063505.</Citation></Reference><Reference><Citation>Vernon SD, Funk S, Bateman L, et al. Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front Med. 2022;9:917019.</Citation></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2022.</Citation></Reference><Reference><Citation>Centre BH. NASA 10 minute lean test. Instructions for providers. 2023. Accessed December 27, 2022. https://batemanhornecenter.org/wp-content/uploads/filebase/providers/mecfs/10-Minute-NASA-Lean-Test-Clinician-Instructions-06_12_2022.pdf</Citation></Reference><Reference><Citation>Bashir M, Ahluwalia H, Khan T, Sayeed SI. Role of NASA 10-minute lean test in diagnosing postural orthostatic tachycardia syndrome: a preliminary study in young population. Italian J&#xa0;Med. 2021;15(2). https://doi.org/10.4081/itjm.2021.1340</Citation></Reference><Reference><Citation>England NHS. COVID-19 post-covid assessment service. 2023. Accessed December 27, 2023.&#xa0;https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-post-covid-assessment-service/</Citation></Reference><Reference><Citation>Monaghan A, Jennings G, Xue F, Byrne L, Duggan E, Romero-Ortuno R. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front Physiol. 2022;13:833650.</Citation></Reference><Reference><Citation>Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. Can Med Assoc J. 2022;194(10):E378-E385.</Citation></Reference><Reference><Citation>van Campen CMC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin&#xa0;Neurophysiol&#xa0;Practice. 2020;5:50-58.</Citation></Reference><Reference><Citation>van Campen CMC, Rowe PC, Visser FC. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin&#xa0;Neurophysiol&#xa0;Practice. 2021;6:245-255.</Citation></Reference><Reference><Citation>Sivan M, Corrado J, Mathias C. The adapted autonomic profile (aAP) home-based test for the evaluation of neuro-cardiovascular autonomic dysfunction. Adv Clin Neurosci Rehabil. 2022;21(3):10-13.</Citation></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365-368.</Citation></Reference><Reference><Citation>Lam MHB. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142-2147.</Citation></Reference><Reference><Citation>Lau ST, Yu WC, Mok NS, Tsui PT, Tong WL, Cheng WC. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS). Int J Cardiol. 2005;100(1):167-169.</Citation></Reference><Reference><Citation>Sivan M, McKeever V, Natt M, Newton J. A global need for more awareness of dysautonomia in postviral syndromes. J Med Virol. 2023;95(8):e29048.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>